{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:51:21Z","timestamp":1791319881800,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R44AI136176"],"award-info":[{"award-number":["R44AI136176"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lanmic.2026.101521","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:51:30Z","timestamp":1790797890000},"page":"101521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A competitive BB-ELISA for anti-toxin B neutralising antibodies in assessing risk of recurrent Clostridioides difficile infection: a retrospective cohort study from the MODIFY I and II trials"],"prefix":"10.1016","author":[{"given":"Hua","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e9nie","family":"Bass\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6645-406X","authenticated-orcid":false,"given":"Taryn","family":"Eubank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Saint Fleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik C","family":"von Rosenvinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin W","family":"Garey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8685-1812","authenticated-orcid":false,"given":"Hanping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2026.101521_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41579-025-01242-2","article-title":"Clostridioides difficile pathogenesis and control","volume":"24","author":"Chilton","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.lanmic.2026.101521_bib3","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/JCM.38.6.2386-2388.2000","article-title":"Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea","volume":"38","author":"Barbut","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.lanmic.2026.101521_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jinf.2009.03.010","article-title":"Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes","volume":"58","author":"Johnson","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.lanmic.2026.101521_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamainternmed.2016.9045","article-title":"Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection","volume":"177","author":"Stevens","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.lanmic.2026.101521_bib6","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/nature07822","article-title":"Toxin B is essential for virulence of Clostridium difficile","volume":"458","author":"Lyras","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.lanmic.2026.101521_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature09397","article-title":"The role of toxin A and toxin B in Clostridium difficile infection","volume":"467","author":"Kuehne","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.lanmic.2026.101521_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/cid\/ciz809","article-title":"Effect of endogenous Clostridioides difficile toxin antibodies on recurrence of C. difficile infection","volume":"71","author":"Kelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101521_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa1602615","article-title":"Bezlotoxumab for prevention of recurrent Clostridium difficile infection","volume":"376","author":"Wilcox","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanmic.2026.101521_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/infdis\/jis669","article-title":"Antibody against TcdB, but not TcdA, prevents development of gastrointestinal and systemic Clostridium difficile disease","volume":"207","author":"Steele","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101521_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2024.102842","article-title":"The impact of existing total anti-toxin B IgG immunity in outcomes of recurrent Clostridioides difficile infection","volume":"87","author":"Rigo","year":"2024","journal-title":"Anaerobe"},{"key":"10.1016\/j.lanmic.2026.101521_bib12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.vaccine.2009.10.144","article-title":"Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)","volume":"28","author":"Leav","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2026.101521_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/infdis\/jir748","article-title":"Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models","volume":"205","author":"Steele","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101521_bib14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/infdis\/jiu196","article-title":"A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice","volume":"210","author":"Yang","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101521_bib15","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1128\/IAI.01577-08","article-title":"Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A","volume":"77","author":"He","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.lanmic.2026.101521_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2020.102299","article-title":"Anti-toxin antibody is not associated with recurrent Clostridium difficile infection","volume":"67","author":"Gilbert","year":"2021","journal-title":"Anaerobe"},{"key":"10.1016\/j.lanmic.2026.101521_bib17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41594-019-0268-0","article-title":"Structure of the full-length Clostridium difficile toxin B","volume":"26","author":"Chen","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.lanmic.2026.101521_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1128\/IAI.02316-14","article-title":"Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis","volume":"83","author":"Li","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.lanmic.2026.101521_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1471-2180-8-192","article-title":"Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium","volume":"8","author":"Yang","year":"2008","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.lanmic.2026.101521_bib20","article-title":"Identification of toxemia in patients with Clostridium difficile infection","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lanmic.2026.101521_bib21","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/IAI.00215-12","article-title":"A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection","volume":"80","author":"Wang","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.lanmic.2026.101521_bib22","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3390\/s23042333","article-title":"A comparative study of the use of stratified cross-validation and distribution-balanced stratified cross-validation in imbalanced learning","volume":"23","author":"Szeghalmy","year":"2023","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.lanmic.2026.101521_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/bimj.200710415","article-title":"Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection","volume":"50","author":"Ruopp","year":"2008","journal-title":"Biom J"},{"key":"10.1016\/j.lanmic.2026.101521_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4172\/2161-1165.1000227","article-title":"Multicollinearity in regression analyses conducted in epidemiologic studies","volume":"6","author":"Vatcheva","year":"2016","journal-title":"Epidemiology (Sunnyvale)"},{"key":"10.1016\/j.lanmic.2026.101521_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/oxfordjournals.aje.a113284","article-title":"A review of goodness of fit statistics for use in the development of logistic regression models","volume":"115","author":"Lemeshow","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.lanmic.2026.101521_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax4905","article-title":"A probiotic yeast-based immunotherapy against Clostridioides difficile infection","volume":"12","author":"Chen","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lanmic.2026.101521_bib27","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101521_bib28","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1093\/infdis\/jiaf423","article-title":"Epitope conservation of AZD5148, a broadly neutralizing anti-toxin B monoclonal antibody, among diverse and global contemporary Clostridioides difficile isolates","volume":"232","author":"Mahool","year":"2025","journal-title":"J Infect Dis"},{"issue":"suppl 6","key":"10.1016\/j.lanmic.2026.101521_bib29","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.1093\/cid\/ciad642","article-title":"Review article: safety of live biotherapeutic products used for the prevention of Clostridioides difficile infection recurrence","volume":"77","author":"Gonzales-Luna","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101521_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098400","article-title":"Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review","volume":"9","author":"Abou Chakra","year":"2014","journal-title":"PLoS One"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266652472600176X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266652472600176X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:04:56Z","timestamp":1791317096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266652472600176X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S266652472600176X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101521","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A competitive BB-ELISA for anti-toxin B neutralising antibodies in assessing risk of recurrent Clostridioides difficile infection: a retrospective cohort study from the MODIFY I and II trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101521"}}